Data search
Results for MligTC455_10659
| Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Annotation |
|---|---|---|---|---|---|---|
| MligTC455_10659 | 3 | 0.05 | Mlig455_021883 | Neo: - Age: - |
Mlig455_021883 {REF} {Length: 232} {NoTransDecoderORF} {RNA1310_77982} {RNA815_38187} |
Cumulative graph for MligTC455_10659
Region-enriched expression
| Region | logFC | logCPM | Pvalue | FDR | Specificity |
|---|---|---|---|---|---|
| RegionR1 | - | - | - | - | |
| RegionR2 | - | - | - | - | |
| RegionR3 | - | - | - | - | |
| RegionR4 | - | - | - | - | |
| RegionR5 | - | - | - | - | |
| RegionR6 | - | - | - | - | |
| RegionR7 | - | - | - | - | |
| RegionR8 | - | - | - | - |
Regeneration-enriched expression
| Region | logFC | logCPM | PValue | FDR | Specificity |
|---|---|---|---|---|---|
| RegenerationR1 | - | - | - | - | |
| RegenerationR2 | - | - | - | - | |
| RegenerationR3 | - | - | - | - | |
| RegenerationR4 | - | - | - | - | |
| RegenerationR5 | - | - | - | - | |
| RegenerationR6 | - | - | - | - | |
| RegenerationBL | - | - | - | - | |
| RegenerationTP | - | - | - | - |
Genes with expression patterns similar to MligTC455_10659
| Nr. | Cluster | Total UMI counts | Global CPM | Transcripts | Categories | Human homolog | Σ Spearman correlations | Int1 | Int2 | Int3 | Reg1 | Reg2 | Reg3 | Annotation |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. | MligTC455_10659 | 3 | 0.05 | Mlig455_021883 | Neo: - Age: - |
1 | - | - | - | - | 1.000 | - | Mlig455_021883 {REF} {Length: 232} {NoTransDecoderORF} {RNA1310_77982} {RNA815_38187} | |
| 2. | MligTC455_26982 | 6 | 0.13 | Mlig455_012994 | Neo: - Age: - |
ANKRD50 | 1 | - | - | - | - | 1.000 | - | Mlig455_012994 {REF} {Length: 5592} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=123.6]; Ankyrin repeat [PF00023.32, score=81.6]; Ankyrin repeats (many copies) [PF13857.8, score=78.7]; Ankyrin repeats (many copies) [PF13637.8, score=75.9]; Ankyrin repeat [PF13606.8, score=69.3]; Mab-21 protein [PF03281.16, score=35.4]} {Human: ENSG00000151458, ANKRD50, ankyrin repeat domain 50, [Score=85.9, Expect=4e-16]} {Mouse: ENSMUSG00000044864, Ankrd50, ankyrin repeat domain 50, [Score=84.3, Expect=9e-16]} {Dmel: FBgn0011747, Ank, Ankyrin, [Score=80.1, Expect=1e-14]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=64.7, Expect=5e-10]} {Smed: dd_Smed_v6_4322_0_1, dd_Smed_v6_4322_0_1, [Score=67.0, Expect=6e-11]} {RNA1509_2705} {RNA1310_4888.2} {RNA815_10746} |
| 3. | MligTC455_12384 | 30 | 0.62 | Mlig455_014121, Mlig455_014129 | Neo: - Age: - Regeneration-downregulated R2: -5.903 Regeneration-depleted R2: -5.903 |
MARK3, MARK4 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_014121 {REF} {Length: 3626} {Pfam: Protein kinase domain [PF00069.27, score=234.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=140.0]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=28.3]; Kinase-like [PF14531.8, score=26.9]; ABC1 atypical kinase-like domain [PF03109.18, score=21.4]; Ternary complex associated domain 9 [PF19974.1, score=18.3]} {Human: ENSG00000007047, MARK4, microtubule affinity regulating kinase 4, [Score=219, Expect=7e-60]; ENSG00000072518, MARK2, microtubule affinity regulating kinase 2, [Score=215, Expect=2e-58]; ENSG00000075413, MARK3, microtubule affinity regulating kinase 3, [Score=212, Expect=2e-57]} {Mouse: ENSMUSG00000030397, Mark4, MAP/microtubule affinity regulating kinase 4, [Score=217, Expect=4e-59]; ENSMUSG00000024969, Mark2, MAP/microtubule affinity regulating kinase 2, [Score=215, Expect=1e-58]; ENSMUSG00000007411, Mark3, MAP/microtubule affinity regulating kinase 3, [Score=213, Expect=1e-57]} {Dmel: FBgn0026063, KP78b, [Score=218, Expect=1e-60]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=220, Expect=5e-59]} {Smed: dd_Smed_v6_14823_0_1, dd_Smed_v6_14823_0_1, [Score=414, Expect=7e-133]} {RNA1310_41210} {RNA815_38347} Mlig455_014129 {REF} {Length: 3531} {Pfam: Protein kinase domain [PF00069.27, score=107.2]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=69.2]} {Human: ENSG00000075413, MARK3, microtubule affinity regulating kinase 3, [Score=93.2, Expect=3e-19]} {Mouse: ENSMUSG00000030397, Mark4, MAP/microtubule affinity regulating kinase 4, [Score=86.7, Expect=3e-17]; ENSMUSG00000009772, Nuak2, NUAK family, SNF1-like kinase, 2, [Score=84.0, Expect=2e-16]; ENSMUSG00000024969, Mark2, MAP/microtubule affinity regulating kinase 2, [Score=83.2, Expect=4e-16]} {Dmel: FBgn0262103, Sik3, Salt-inducible kinase 3, [Score=87.4, Expect=2e-17]} {Celegans: WBGene00003916, par-1, Serine/threonine-protein kinase par-1, [Score=86.3, Expect=3e-17]} {Smed: dd_Smed_v6_14823_0_1, dd_Smed_v6_14823_0_1, [Score=151, Expect=1e-38]} {RNA1310_80369} {RNA815_38347} |
| 4. | MligTC455_36331 | 1502 | 31.28 | Mlig455_013523, Mlig455_013524, Mlig455_061355, Mlig455_061362 | Neo: - Age: logFC(26M/2M)=1.048 Region-specific R3: 5.547 Region-enriched R3: 6.000/0.00000 |
KREMEN2 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_013523 {REF} {Length: 404} {Pfam: F5/8 type C domain [PF00754.27, score=62.5]; Small zinc finger protein HVO_2753-like, Zn-binding pocket [PF07754.13, score=19.8]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=52.4, Expect=5e-08]} {RNA1509_2195} {RNA1310_4987.1} {RNA815_612.1} Mlig455_013524 {REF} {Length: 932} {Pfam: F5/8 type C domain [PF00754.27, score=31.2]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=52.0, Expect=2e-08]} {RNA1509_21733} {RNA1310_11857} {RNA815_612.1} Mlig455_061355 {REF} {Length: 1985} {Pfam: F5/8 type C domain [PF00754.27, score=62.5]; Small zinc finger protein HVO_2753-like, Zn-binding pocket [PF07754.13, score=19.8]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=52.4, Expect=5e-08]} {RNA1509_21733} {RNA1310_11857} {RNA815_612.1} Mlig455_061362 {REF} {Length: 6001} {Pfam: F5/8 type C domain [PF00754.27, score=149.8]; WSC domain [PF01822.21, score=62.9]; Clip-domain serine protease homolog Scarface [PF18399.3, score=38.7]; Phostensin PP1-binding and SH3-binding region [PF13914.8, score=28.9]; Influenza A Proapoptotic protein [PF11986.10, score=22.3]; NgoBV restriction endonuclease [PF09564.12, score=20.4]} {Human: ENSG00000131650, KREMEN2, kringle containing transmembrane protein 2, [RH, Score=66.2, Expect=3e-10]} {Mouse: ENSMUSG00000040680, Kremen2, kringle containing transmembrane protein 2, [RH, Score=65.5, Expect=4e-10]} {Smed: dd_Smed_v6_52492_0_1, dd_Smed_v6_52492_0_1, [Score=56.2, Expect=6e-09]} {RNA1509_15294, RNA1509_21733} {RNA1310_11815, RNA1509_21733} {RNA1509_21733, RNA815_612.1} |
| 5. | MligTC455_45074 | 9 | 0.19 | Mlig455_067112 | Neo: - Age: - |
ASIC5 | 0.998 | - | - | - | - | 0.998 | - | Mlig455_067112 {REF} {Length: 2924} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=199.0]} {Human: ENSG00000256394, ASIC5, acid sensing ion channel subunit family member 5, [Score=63.5, Expect=9e-10]} {Mouse: ENSMUSG00000028008, Asic5, acid-sensing (proton-gated) ion channel family member 5, [Score=61.6, Expect=2e-09]} {Celegans: WBGene00010278, F58G6.8, [Score=56.6, Expect=6e-09]} {Smed: dd_Smed_v6_12037_0_1, dd_Smed_v6_12037_0_1, [RH, Score=441, Expect=1e-145]} {RNA1509_30695} {RNA1310_7174.1} {RNA815_3961} |
| 6. | MligTC455_45629 | 24 | 0.49 | Mlig455_032109 | Neo: - Age: - |
0.998 | - | - | - | - | 0.998 | - | Mlig455_032109 {REF} {Length: 788} {Pfam: Pancreatic hormone peptide [PF00159.20, score=28.0]} {RNA1509_59316} {RNA1310_91502} {RNA815_61453} | |
| 7. | MligTC455_05930 | 7 | 0.14 | Mlig455_024449 | Neo: - Age: - |
0.996 | - | - | - | - | 0.996 | - | Mlig455_024449 {REF} {Length: 721} {RNA1310_116165} | |
| 8. | MligTC455_44707 | 2674 | 55.7 | Mlig455_060882 | Neo: - Age: Up-Up-Up, logFC(26M/2M)=3.903 Region-enriched R3: 5.097/0.00000 |
TLL1 | 0.993 | - | - | - | - | 0.993 | - | Mlig455_060882 {REF} {Length: 934} {Pfam: Astacin (Peptidase family M12A) [PF01400.26, score=170.1]} {Human: ENSG00000038295, TLL1, tolloid like 1, [Score=118, Expect=9e-31]; ENSG00000188886, ASTL, astacin like metalloendopeptidase, [Score=117, Expect=5e-30]; ENSG00000141434, MEP1B, meprin A subunit beta, [Score=115, Expect=1e-28]; ENSG00000168487, BMP1, bone morphogenetic protein 1, [Score=114, Expect=1e-28]} {Mouse: ENSMUSG00000053626, Tll1, tolloid-like, [Score=119, Expect=3e-30]; ENSMUSG00000024313, Mep1b, meprin 1 beta, [Score=117, Expect=1e-29]; ENSMUSG00000022098, Bmp1, bone morphogenetic protein 1, [Score=114, Expect=1e-28]} {Dmel: FBgn0028948, CG15253, [RH, Score=152, Expect=2e-45]} {Celegans: WBGene00003523, nas-4, Zinc metalloproteinase nas-4, [Score=129, Expect=5e-36]} {Smed: dd_Smed_v6_961_0_1, dd_Smed_v6_961_0_1, [Score=109, Expect=4e-29]} {RNA1509_58597} {RNA1310_40274} {RNA815_19279.1} |
| 9. | MligTC455_34879 | 33 | 0.68 | Mlig455_006955 | Neo: - Age: Up-Down-Down |
0.992 | - | - | - | - | 0.992 | - | Mlig455_006955 {REF} {Length: 5084} {RNA1509_31973} {RNA1310_5137.1} {RNA815_39446} | |
| 10. | MligTC455_15966 | 5454 | 113.63 | Mlig455_003058, Mlig455_003264, Mlig455_062835 | Neo: - Age: - Region-specific R3: 6.443 Region-enriched R3: 6.417/0.00000 |
LPA | 0.991 | - | - | - | - | 0.991 | - | Mlig455_003058 {REF} {Length: 3386} {Pfam: F5/8 type C domain [PF00754.27, score=107.6]; Kringle domain [PF00051.20, score=41.3]; Fascin domain [PF06268.15, score=35.9]; Eukaryotic initiation factor 4E [PF01652.20, score=21.9]} {Human: ENSG00000198670, LPA, lipoprotein(a), [Score=55.5, Expect=3e-07]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=56.2, Expect=1e-07]} {Smed: dd_Smed_v6_10257_0_1, dd_Smed_v6_10257_0_1, [Score=51.2, Expect=2e-06]} {RNA1509_1148} {RNA1310_4281.1} {RNA815_1448} Mlig455_003264 {REF} {Length: 2972} {Pfam: F5/8 type C domain [PF00754.27, score=134.3]; Kringle domain [PF00051.20, score=40.8]; Fascin domain [PF06268.15, score=35.7]; Homotrimeric ring hydroxylase [PF11723.10, score=22.8]; Eukaryotic initiation factor 4E [PF01652.20, score=21.8]} {Human: ENSG00000198670, LPA, lipoprotein(a), [Score=55.5, Expect=4e-07]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=56.2, Expect=2e-07]} {Smed: dd_Smed_v6_13385_0_1, dd_Smed_v6_13385_0_1, [Score=51.6, Expect=2e-06]} {RNA1509_1148} {RNA1310_4281.1} {RNA815_1448} Mlig455_062835 {REF} {Length: 3978} {Pfam: F5/8 type C domain [PF00754.27, score=107.6]; Kringle domain [PF00051.20, score=41.3]; Fascin domain [PF06268.15, score=35.9]; Eukaryotic initiation factor 4E [PF01652.20, score=21.9]} {Human: ENSG00000198670, LPA, lipoprotein(a), [Score=55.5, Expect=3e-07]} {Mouse: ENSMUSG00000059481, Plg, plasminogen, [Score=56.2, Expect=1e-07]} {Smed: dd_Smed_v6_10257_0_1, dd_Smed_v6_10257_0_1, [Score=51.2, Expect=2e-06]} {RNA1509_1148, RNA1509_8252} {RNA1310_4281.1, RNA1509_8252} {RNA1509_8252, RNA815_1448} |
| 11. | MligTC455_33080 | 814 | 16.95 | Mlig455_049373 | Neo: - Age: Down-Down-Up, logFC(26M/2M)=-0.494 Region-specific R3: 6.455 Region-enriched R3: 6.051/0.00000 |
FN1 | 0.991 | - | - | - | - | 0.991 | - | Mlig455_049373 {REF} {Length: 1253} {Pfam: Fibronectin type II domain [PF00040.21, score=92.6]; Calcium-binding EGF domain [PF07645.17, score=30.5]} {Human: ENSG00000115414, FN1, fibronectin 1, [RH, Score=83.6, Expect=7e-18]} {Mouse: ENSMUSG00000026193, Fn1, fibronectin 1, [RH, Score=85.5, Expect=1e-18]} {Celegans: WBGene00007170, B0393.5, [Score=51.2, Expect=2e-07]} {Smed: dd_Smed_v6_14558_0_1, dd_Smed_v6_14558_0_1, [Score=52.0, Expect=5e-08]} {RNA1509_35441, RNA1509_9115} {RNA1310_32646.1, RNA1509_35441, RNA1509_9115} {RNA1509_35441, RNA1509_9115, RNA815_14924.1} |
| 12. | MligTC455_02266 | 8 | 0.16 | Mlig455_069150 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_069150 {REF} {Length: 532} {RNA1509_43209} {RNA1310_129145} {RNA815_24538} | |
| 13. | MligTC455_06444 | 29 | 0.61 | Mlig455_009655 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_009655 {REF} {Length: 2004} {RNA1310_35837.1} {RNA815_50334} | |
| 14. | MligTC455_24311 | 5 | 0.1 | Mlig455_040354 | Neo: - Age: - |
0.988 | - | - | - | - | 0.988 | - | Mlig455_040354 {REF} {Length: 526} {NoTransDecoderORF} {RNA1310_89152} {RNA815_41473} | |
| 15. | MligTC455_41907 | 14 | 0.3 | Mlig455_020658 | Neo: - Age: Up-Down-Down |
CADPS | 0.988 | - | - | - | - | 0.988 | - | Mlig455_020658 {REF} {Length: 4466} {TRANSSPLICED} {Pfam: MUN domain [PF06292.19, score=403.4]; PH domain [PF00169.31, score=33.8]; C2 domain [PF00168.32, score=20.9]} {Human: ENSG00000163618, CADPS, calcium dependent secretion activator, [Score=1257, Expect=0.0]; ENSG00000081803, CADPS2, calcium dependent secretion activator 2, [Score=1224, Expect=0.0]} {Mouse: ENSMUSG00000054423, Cadps, Ca2+-dependent secretion activator, [Score=1243, Expect=0.0]; ENSMUSG00000017978, Cadps2, Ca2+-dependent activator protein for secretion 2, [Score=1224, Expect=0.0]} {Dmel: FBgn0053653, Cadps, Calcium-dependent secretion activator, [Score=1279, Expect=0.0]} {Celegans: WBGene00006767, unc-31, Calcium-dependent secretion activator, [Score=1090, Expect=0.0]} {Smed: dd_Smed_v6_11725_0_1, dd_Smed_v6_11725_0_1, [Score=1281, Expect=0.0]} {RNA1509_26708} {RNA1310_4475, RNA1509_26708} {RNA1509_26708, RNA815_2341} |
| 16. | MligTC455_29880 | 6 | 0.13 | Mlig455_032204 | Neo: - Age: - |
TMEM26 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_032204 {REF} {Length: 2863} {Pfam: Transmembrane protein 26 [PF09772.11, score=248.5]; Ankyrin repeats (many copies) [PF13637.8, score=46.6]; Ankyrin repeats (many copies) [PF13857.8, score=46.0]; Ankyrin repeats (3 copies) [PF12796.9, score=43.5]; Ankyrin repeat [PF13606.8, score=36.8]; Ankyrin repeat [PF00023.32, score=33.8]} {Human: ENSG00000196932, TMEM26, transmembrane protein 26, [Score=109, Expect=2e-25]} {Mouse: ENSMUSG00000060044, Tmem26, transmembrane protein 26, [Score=111, Expect=3e-26]} {Dmel: FBgn0039429, CG14238, [Score=149, Expect=2e-38]} {Celegans: WBGene00022469, Y119C1B.3, [Score=125, Expect=1e-30]} {Smed: dd_Smed_v6_30929_0_1, dd_Smed_v6_30929_0_1, [Score=119, Expect=6e-29]} {RNA1509_44391} {RNA1310_35836} {RNA815_14435} |
| 17. | MligTC455_38173 | 4 | 0.09 | Mlig455_041306 | Neo: - Age: Up-Down-Down |
DNAH17 | 0.983 | - | - | - | - | 0.983 | - | Mlig455_041306 {REF} {Length: 2376} {Pfam: Dynein heavy chain C-terminal domain [PF18199.3, score=349.5]; Dynein heavy chain AAA lid domain [PF18198.3, score=175.6]; Dynein heavy chain region D6 P-loop domain [PF03028.17, score=131.3]} {Human: ENSG00000187775, DNAH17, dynein axonemal heavy chain 17, [Score=1108, Expect=0.0]; ENSG00000007174, DNAH9, dynein axonemal heavy chain 9, [Score=1103, Expect=0.0]} {Mouse: ENSMUSG00000033987, Dnah17, dynein, axonemal, heavy chain 17, [Score=1120, Expect=0.0]; ENSMUSG00000056752, Dnah9, dynein, axonemal, heavy chain 9, [Score=1097, Expect=0.0]} {Dmel: FBgn0013812, Dhc93AB, Dynein heavy chain at 93AB, [Score=1077, Expect=0.0]} {Celegans: WBGene00000485, che-3, Cytoplasmic dynein 2 heavy chain 1, [Score=212, Expect=1e-57]} {Smed: dd_Smed_v6_3670_0_1, dd_Smed_v6_3670_0_1, [Score=1254, Expect=0.0]} {RNA1509_140} {RNA1310_286} {RNA815_831} |
| 18. | MligTC455_26578 | 2390 | 49.79 | Mlig455_013860 | Neo: - Age: Up-Down-Down Region-specific R3: 6.620 Region-enriched R3: 6.016/0.00000 |
HMCN1 | 0.978 | - | - | - | - | 0.978 | - | Mlig455_013860 {REF} {Length: 12718} {Pfam: WSC domain [PF01822.21, score=1269.3]; F5/8 type C domain [PF00754.27, score=142.9]; von Willebrand factor type A domain [PF13519.8, score=57.1]; von Willebrand factor type A domain [PF00092.30, score=46.6]; von Willebrand factor type A domain [PF13768.8, score=24.3]; Clip-domain serine protease homolog Scarface [PF18399.3, score=21.2]; NUMOD3 motif [PF07460.13, score=21.0]; Dirigent-like protein [PF03018.16, score=18.7]} {Human: ENSG00000143341, HMCN1, hemicentin 1, [Score=79.0, Expect=2e-13]; ENSG00000075035, WSCD2, WSC domain containing 2, [Score=79.0, Expect=1e-13]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=79.0, Expect=2e-13]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=76.3, Expect=6e-13]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=62.8, Expect=6e-09]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=92.8, Expect=6e-18]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=94.7, Expect=1e-18]} {RNA1509_538} {RNA1310_184.1} {RNA815_195.1} |
| 19. | MligTC455_02760 | 16 | 0.32 | Mlig455_019892 | Neo: - Age: - |
0.977 | - | - | - | - | 0.977 | - | Mlig455_019892 {REF} {Length: 2308} {NoTransDecoderORF} | |
| 20. | MligTC455_25289 | 6532 | 136.09 | Mlig455_038419 | Neo: - Age: Down-Up-Up Region-specific R3: 6.513 Region-enriched R3: 6.333/0.00000 |
TNN | 0.977 | - | - | - | - | 0.977 | - | Mlig455_038419 {REF} {Length: 1476} {Pfam: Fibrinogen beta and gamma chains, C-terminal globular domain [PF00147.20, score=129.4]} {Human: ENSG00000120332, TNN, tenascin N, [Score=120, Expect=4e-29]; ENSG00000136859, ANGPTL2, angiopoietin like 2, [Score=119, Expect=5e-29]; ENSG00000116194, ANGPTL1, angiopoietin like 1, [Score=116, Expect=3e-28]} {Mouse: ENSMUSG00000026725, Tnn, tenascin N, [Score=124, Expect=3e-30]; ENSMUSG00000033544, Angptl1, angiopoietin-like 1, [Score=120, Expect=1e-29]; ENSMUSG00000026938, Fcna, ficolin A, [Score=119, Expect=4e-30]; ENSMUSG00000004105, Angptl2, angiopoietin-like 2, [Score=119, Expect=2e-29]} {Dmel: FBgn0051832, CG31832, [Score=105, Expect=4e-26]} {Celegans: WBGene00020516, T15B7.1, [Score=66.2, Expect=8e-12]} {Smed: dd_Smed_v6_18326_0_1, dd_Smed_v6_18326_0_1, [Score=85.9, Expect=5e-18]} {RNA1509_45498, RNA1509_740} {RNA1310_24610.1, RNA1509_45498, RNA1509_740} {RNA1509_45498, RNA1509_740, RNA815_8978.2} |
| 21. | MligTC455_49075 | 21 | 0.43 | Mlig455_054251 | Neo: - Age: - Region-enriched R3: 4.361/0.02976 |
SCNN1D | 0.971 | - | - | - | - | 0.971 | - | Mlig455_054251 {REF} {Length: 2989} {Pfam: Amiloride-sensitive sodium channel [PF00858.26, score=231.8]} {Human: ENSG00000162572, SCNN1D, sodium channel epithelial 1 delta subunit, [Score=60.5, Expect=7e-09]} {Mouse: ENSMUSG00000030340, Scnn1a, sodium channel, nonvoltage-gated 1 alpha, [Score=60.1, Expect=6e-09]} {Celegans: WBGene00012116, del-4, DEgenerin Like, [Score=91.3, Expect=4e-19]} {Smed: dd_Smed_v6_9790_0_1, dd_Smed_v6_9790_0_1, [Score=113, Expect=3e-26]} {RNA1509_33969} {RNA1310_7585} {RNA815_18176} |
| 22. | MligTC455_51959 | 152 | 3.16 | Mlig455_055205 | Neo: - Age: - Region-specific R3: 4.364 Region-enriched R3: 4.131/0.00000 |
WNT9A | 0.97 | - | - | - | - | 0.970 | - | Mlig455_055205 {REF} {Length: 3292} {Pfam: wnt family [PF00110.21, score=143.6]} {Human: ENSG00000143816, WNT9A, Wnt family member 9A, [Score=67.8, Expect=1e-11]; ENSG00000162552, WNT4, Wnt family member 4, [Score=67.0, Expect=2e-11]} {Mouse: ENSMUSG00000036856, Wnt4, wingless-type MMTV integration site family, member 4, [Score=67.0, Expect=1e-11]; ENSMUSG00000000126, Wnt9a, wingless-type MMTV integration site family, member 9A, [Score=66.6, Expect=2e-11]} {Dmel: FBgn0031902, Wnt6, Wnt oncogene analog 6, [Score=68.2, Expect=6e-12]} {Celegans: WBGene00003395, mom-2, [Score=61.6, Expect=4e-10]} {Smed: dd_Smed_v6_14865_0_1, dd_Smed_v6_14865_0_1, [Score=69.7, Expect=7e-13]} {RNA1509_20496} {RNA1310_26738.1} {RNA815_14333} |
| 23. | MligTC455_53129 | 224 | 4.66 | Mlig455_002408, Mlig455_057628 | Neo: - |
REG1A | 0.97 | - | - | - | - | 0.970 | - | Mlig455_002408 {REF} {Length: 1777} {Pfam: Lectin C-type domain [PF00059.23, score=40.5]; UL45 protein, carbohydrate-binding C-type lectin-like [PF05473.14, score=24.1]} {Human: ENSG00000115386, REG1A, regenerating family member 1 alpha, [Score=57.4, Expect=5e-10]} {Mouse: ENSMUSG00000023140, Reg2, regenerating islet-derived 2, [Score=52.0, Expect=3e-08]} {RNA1509_7169} {RNA1310_18329} {RNA815_9235} Mlig455_057628 {REF} {Length: 1695} {Pfam: Lectin C-type domain [PF00059.23, score=65.0]; UL45 protein, carbohydrate-binding C-type lectin-like [PF05473.14, score=24.5]} {Human: ENSG00000115386, REG1A, regenerating family member 1 alpha, [Score=57.0, Expect=3e-09]} {Mouse: ENSMUSG00000023140, Reg2, regenerating islet-derived 2, [Score=51.6, Expect=1e-07]} {RNA1509_7169} {RNA1310_18329} {RNA815_9235} |
| 24. | MligTC455_16798 | 44 | 0.91 | Mlig455_035236, Mlig455_035279 | Neo: - Age: logFC(26M/2M)=2.157 |
0.968 | - | - | - | - | 0.968 | - | Mlig455_035236 {REF} {Length: 2278} {RNA1310_17149} Mlig455_035279 {REF} {Length: 2771} {RNA1509_59452} {RNA1310_17149} {RNA815_31994} |
|
| 25. | MligTC455_00525 | 15 | 0.32 | Mlig455_005625 | Neo: - Age: - Region-enriched R4: 7.270/0.00343 |
0.966 | - | - | - | - | 0.966 | - | Mlig455_005625 {REF} {Length: 229} {NoTransDecoderORF} {RNA1509_39201} {RNA1310_112206} | |
| 26. | MligTC455_20267 | 11467 | 238.9 | Mlig455_009795, Mlig455_010377 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.495 Region-enriched R3: 1.040/0.00004 |
EIF4EBP2 | 0.966 | - | - | - | - | 0.966 | - | Mlig455_009795 {REF} {Length: 1589} {TRANSSPLICED} {Pfam: Eukaryotic translation initiation factor 4E binding protein (EIF4EBP) [PF05456.13, score=139.0]} {Human: ENSG00000148730, EIF4EBP2, eukaryotic translation initiation factor 4E binding protein 2, [RH, Score=107, Expect=4e-31]} {Mouse: ENSMUSG00000020091, Eif4ebp2, eukaryotic translation initiation factor 4E binding protein 2, [RH, Score=108, Expect=2e-31]} {Dmel: FBgn0261560, Thor, [RH, Score=73.9, Expect=3e-18]} {Smed: dd_Smed_v6_1204_0_1, dd_Smed_v6_1204_0_1, [RH, Score=85.1, Expect=6e-23]} {RNA1509_10337, RNA1509_27103, RNA1509_38027, RNA1509_47490, RNA1509_48163, RNA1509_58432} {RNA1310_20180.1, RNA1509_10337, RNA1509_27103, RNA1509_38027, RNA1509_47490, RNA1509_48163, RNA1509_58432} {RNA1509_10337, RNA1509_27103, RNA1509_38027, RNA1509_47490, RNA1509_48163, RNA1509_58432, RNA815_7917} Mlig455_010377 {REF} {Length: 1592} {TRANSSPLICED} {Pfam: Eukaryotic translation initiation factor 4E binding protein (EIF4EBP) [PF05456.13, score=139.0]} {Human: ENSG00000148730, EIF4EBP2, eukaryotic translation initiation factor 4E binding protein 2, [RH, Score=107, Expect=4e-31]} {Mouse: ENSMUSG00000020091, Eif4ebp2, eukaryotic translation initiation factor 4E binding protein 2, [RH, Score=108, Expect=2e-31]} {Dmel: FBgn0261560, Thor, [RH, Score=73.9, Expect=3e-18]} {Smed: dd_Smed_v6_1204_0_1, dd_Smed_v6_1204_0_1, [RH, Score=85.1, Expect=6e-23]} {RNA1509_27504, RNA1509_45764, RNA1509_48163, RNA1509_5688, RNA1509_59841} {RNA1310_20180.1, RNA1509_27504, RNA1509_45764, RNA1509_5688, RNA1509_59841} {RNA1509_27504, RNA1509_45764, RNA1509_5688, RNA1509_59841, RNA815_7917} |
| 27. | MligTC455_21799 | 403 | 8.4 | Mlig455_030420 | Neo: - Age: Up-Down-Down Region-specific R3: 6.931 Region-enriched R3: 6.913/0.00000 |
HMCN2 | 0.965 | - | - | - | - | 0.965 | - | Mlig455_030420 {REF} {Length: 1479} {Pfam: WSC domain [PF01822.21, score=113.5]; von Willebrand factor type A domain [PF13519.8, score=34.1]; von Willebrand factor type A domain [PF00092.30, score=27.0]; von Willebrand factor type A domain [PF13768.8, score=20.5]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=79.0, Expect=8e-15]; ENSG00000143341, HMCN1, hemicentin 1, [Score=75.1, Expect=1e-13]} {Mouse: ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=76.3, Expect=3e-14]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=73.9, Expect=9e-14]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=77.4, Expect=6e-15]} {RNA1509_14078, RNA1509_53874} {RNA1310_11605.2, RNA1509_53874} {RNA1509_53874, RNA815_1633.1} |
| 28. | MligTC455_21798 | 400 | 8.34 | Mlig455_030373 | Neo: - Age: Up-Down-Down Region-specific R3: 7.095 Region-enriched R3: 6.951/0.00000 |
HMCN2 | 0.964 | - | - | - | - | 0.964 | - | Mlig455_030373 {REF} {Length: 4938} {Pfam: WSC domain [PF01822.21, score=501.5]; von Willebrand factor type A domain [PF13519.8, score=70.0]; LCCL domain [PF03815.21, score=47.0]; von Willebrand factor type A domain [PF13768.8, score=44.2]; Histone deacetylation protein Rxt3 [PF08642.12, score=23.7]} {Human: ENSG00000148357, HMCN2, hemicentin 2, [Score=78.6, Expect=1e-13]; ENSG00000143341, HMCN1, hemicentin 1, [Score=75.5, Expect=8e-13]; ENSG00000075035, WSCD2, WSC domain containing 2, [Score=75.5, Expect=5e-13]} {Mouse: ENSMUSG00000055632, Hmcn2, hemicentin 2, [Score=77.8, Expect=1e-13]; ENSMUSG00000063430, Wscd2, WSC domain containing 2, [Score=77.0, Expect=9e-14]; ENSMUSG00000066842, Hmcn1, hemicentin 1, [Score=76.6, Expect=3e-13]} {Dmel: FBgn0015360, oxt, peptide O-xylosyltransferase, [Score=57.8, Expect=8e-08]} {Celegans: WBGene00001863, him-4, Hemicentin; High Incidence of Males (Increased X chromosome loss), [Score=92.0, Expect=3e-18]} {Smed: dd_Smed_v6_1161_0_1, dd_Smed_v6_1161_0_1, [Score=93.2, Expect=1e-18]} {RNA1509_14078, RNA1509_51440} {RNA1310_11605.2, RNA1509_51440} {RNA1509_51440, RNA815_1633.1} |
| 29. | MligTC455_33936 | 62 | 1.29 | Mlig455_061181 | Neo: - Age: Down-Down-Up Region-enriched R3: 4.766/0.00000 |
0.964 | - | - | - | - | 0.964 | - | Mlig455_061181 {REF} {Length: 2443} {Pfam: Fibronectin type II domain [PF00040.21, score=54.5]} {Mouse: ENSMUSG00000054580, Pla2r1, phospholipase A2 receptor 1, [Score=50.1, Expect=2e-06]} {RNA1310_23349.1} {RNA815_44226.1} | |
| 30. | MligTC455_10345 | 30 | 0.63 | Mlig455_018653, Mlig455_018855 | Neo: - Age: - |
0.96 | - | - | - | - | 0.960 | - | Mlig455_018653 {REF} {Length: 1014} Mlig455_018855 {REF} {Length: 1036} |
|
| 31. | MligTC455_38555 | 1592 | 33.16 | Mlig455_042871, Mlig455_042872, Mlig455_042880 | Neo: - Age: Down-Up-Down Region-enriched R3: 3.619/0.00000 |
AMY1B, AMY1C, AMY2B | 0.96 | - | - | - | - | 0.960 | - | Mlig455_042871 {REF} {Length: 656} {Human: ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [Score=136, Expect=1e-38]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [Score=135, Expect=5e-40]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [Score=133, Expect=6e-39]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [Score=133, Expect=6e-39]; ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [Score=132, Expect=2e-36]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [Score=131, Expect=6e-38]; ENSMUSG00000070360, Amy2a1, amylase 2a1, [Score=125, Expect=8e-36]} {Dmel: FBgn0020506, Amyrel, [Score=122, Expect=6e-33]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=106, Expect=4e-27]} {RNA1509_1421} {RNA1310_11165} {RNA815_3708.1} Mlig455_042872 {REF} {Length: 1146} {Pfam: Alpha amylase, C-terminal all-beta domain [PF02806.20, score=43.6]} {Human: ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [Score=315, Expect=1e-104]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [Score=315, Expect=1e-104]; ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [Score=315, Expect=1e-104]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [Score=312, Expect=3e-103]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [Score=312, Expect=2e-103]} {Mouse: ENSMUSG00000096569, Amy2a2, amylase 2a2, [Score=317, Expect=3e-105]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [Score=317, Expect=3e-105]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [Score=317, Expect=3e-105]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [Score=317, Expect=3e-105]; ENSMUSG00000074264, Amy1, amylase 1, salivary, [Score=310, Expect=1e-102]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [Score=269, Expect=7e-87]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=154, Expect=4e-42]} {RNA1509_1421} {RNA1310_7529} {RNA815_3708.1} Mlig455_042880 {REF} {Length: 1770} {Pfam: Alpha amylase, catalytic domain [PF00128.26, score=56.3]; Alpha amylase, C-terminal all-beta domain [PF02806.20, score=42.2]} {Human: ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [RH, Score=588, Expect=0.0]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [RH, Score=588, Expect=0.0]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [RH, Score=588, Expect=0.0]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [RH, Score=587, Expect=0.0]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [RH, Score=585, Expect=0.0]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [RH, Score=580, Expect=0.0]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [RH, Score=570, Expect=0.0]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [RH, Score=570, Expect=0.0]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [RH, Score=570, Expect=0.0]; ENSMUSG00000096569, Amy2a2, amylase 2a2, [RH, Score=570, Expect=0.0]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [RH, Score=492, Expect=4e-171]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=358, Expect=6e-116]} {RNA1509_1421} {RNA1310_7529} {RNA815_3708.1} |
| 32. | MligTC455_07888 | 6 | 0.12 | Mlig455_062425 | Neo: - Age: - |
0.959 | - | - | - | - | 0.959 | - | Mlig455_062425 {REF} {Length: 198} {NoTransDecoderORF} | |
| 33. | MligTC455_01018 | 4 | 0.07 | Mlig455_020251 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_020251 {REF} {Length: 428} {NoTransDecoderORF} {RNA1310_50543} | |
| 34. | MligTC455_06763 | 10 | 0.21 | Mlig455_010608 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_010608 {REF} {Length: 981} {NoTransDecoderORF} {RNA1509_21079} {RNA1310_142796} | |
| 35. | MligTC455_38556 | 168 | 3.5 | Mlig455_049546 | Neo: - Age: logFC(26M/2M)=-0.547 Region-enriched R3: 4.481/0.00055 |
AMY1C | 0.958 | - | - | - | - | 0.958 | - | Mlig455_049546 {REF} {Length: 2273} {Pfam: Alpha amylase, catalytic domain [PF00128.26, score=54.2]; Alpha amylase, C-terminal all-beta domain [PF02806.20, score=41.8]} {Human: ENSG00000187733, AMY1C, amylase, alpha 1C (salivary), [RH, Score=592, Expect=0.0]; ENSG00000237763, AMY1A, amylase, alpha 1A (salivary), [RH, Score=592, Expect=0.0]; ENSG00000174876, AMY1B, amylase, alpha 1B (salivary), [RH, Score=592, Expect=0.0]; ENSG00000240038, AMY2B, amylase, alpha 2B (pancreatic), [RH, Score=591, Expect=0.0]; ENSG00000243480, AMY2A, amylase, alpha 2A (pancreatic), [RH, Score=588, Expect=0.0]} {Mouse: ENSMUSG00000074264, Amy1, amylase 1, salivary, [RH, Score=584, Expect=0.0]; ENSMUSG00000096770, Amy2a4, amylase 2a4, [RH, Score=575, Expect=0.0]; ENSMUSG00000096569, Amy2a2, amylase 2a2, [RH, Score=575, Expect=0.0]; ENSMUSG00000093931, Amy2a3, amylase 2a3, [RH, Score=575, Expect=0.0]; ENSMUSG00000074268, Amy2a5, amylase 2a5, [RH, Score=575, Expect=0.0]} {Dmel: FBgn0000078, Amy-d, Amylase distal, [RH, Score=492, Expect=5e-171]} {Celegans: WBGene00008220, C50B6.7, Alpha-amylase, [Score=359, Expect=2e-116]} {RNA1509_1421} {RNA1310_11165, RNA1509_1421} {RNA1509_1421, RNA815_3708.1} |
| 36. | MligTC455_56713 | 3 | 0.07 | Mlig455_000328 | Neo: - Age: - |
0.958 | - | - | - | - | 0.958 | - | Mlig455_000328 {REF} {Length: 393} {NoTransDecoderORF} | |
| 37. | MligTC455_20548 | 68 | 1.42 | Mlig455_051479 | Neo: - Age: logFC(26M/2M)=0.761 |
FEZF2 | 0.955 | - | - | - | - | 0.955 | - | Mlig455_051479 {REF} {Length: 1530} {Pfam: Zinc finger, C2H2 type [PF00096.28, score=95.0]; C2H2-type zinc finger [PF13894.8, score=72.0]; Zinc-finger double domain [PF13465.8, score=66.9]; Zinc-finger double-stranded RNA-binding [PF12171.10, score=25.8]} {Human: ENSG00000153266, FEZF2, FEZ family zinc finger 2, [Score=299, Expect=2e-98]; ENSG00000128610, FEZF1, FEZ family zinc finger 1, [Score=294, Expect=5e-97]} {Mouse: ENSMUSG00000021743, Fezf2, Fez family zinc finger 2, [Score=302, Expect=5e-100]; ENSMUSG00000029697, Fezf1, Fez family zinc finger 1, [Score=294, Expect=1e-96]} {Dmel: FBgn0031375, erm, earmuff, [Score=301, Expect=5e-98]} {Celegans: WBGene00012639, fezf-1, FEZ Family zinc finger protein, [RH, Score=278, Expect=9e-94]} {Smed: dd_Smed_v6_26394_0_1, dd_Smed_v6_26394_0_1, [Score=255, Expect=1e-84]} {RNA1310_19447} {RNA815_61285} |
| 38. | MligTC455_36828 | 350 | 7.3 | Mlig455_019540 | Neo: - Age: Down-Up-Up, logFC(26M/2M)=0.696 Region-specific R3: 7.604 Region-enriched R3: 8.268/0.00000 |
0.952 | - | - | - | - | 0.952 | - | Mlig455_019540 {REF} {Length: 632} {RNA1509_23357, RNA1509_59583} {RNA1310_46363.1, RNA1509_23357} {RNA1509_23357, RNA815_23794} |